Zenlabs Ethica Limited

BSE:530697 Stock Report

Market Cap: ₹263.7m

Zenlabs Ethica Valuation

Is 530697 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 530697 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 530697's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 530697's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 530697?

Key metric: As 530697 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 530697. This is calculated by dividing 530697's market cap by their current earnings.
What is 530697's PE Ratio?
PE Ratio73.2x
Earnings₹3.60m
Market Cap₹263.72m

Price to Earnings Ratio vs Peers

How does 530697's PE Ratio compare to its peers?

The above table shows the PE ratio for 530697 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average25.2x
SAROJA Saroja Pharma Industries India
32.7xn/a₹233.0m
539938 Medico Intercontinental
12.4xn/a₹592.5m
544143 Royal Sense
40.2xn/a₹1.1b
543594 Dipna Pharmachem
15.2xn/a₹165.2m
530697 Zenlabs Ethica
73.2xn/a₹263.7m

Price-To-Earnings vs Peers: 530697 is expensive based on its Price-To-Earnings Ratio (73.2x) compared to the peer average (25.2x).

Price to Earnings Ratio vs Industry

How does 530697's PE Ratio compare vs other companies in the IN Healthcare Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
523696 Fortis Malar Hospitals
2.1xn/aUS$11.76m
542918 Gian Life Care
4.9xn/aUS$2.33m
No more companies available in this PE range
530697 73.2xIndustry Avg. 41.9xNo. of Companies5PE020406080100+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 530697 is expensive based on its Price-To-Earnings Ratio (73.2x) compared to the Indian Healthcare industry average (41.9x).

Price to Earnings Ratio vs Fair Ratio

What is 530697's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

530697 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio73.2x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 530697's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Medico Intercontinental

₹592.5m

Trades in pharmaceutical products.

539938

₹59.25

7D

28.6%

1Y

-37.0%

N G Industries

₹547.0m

Provides various healthcare services in India.

530897

₹163.25

7D

-2.7%

1Y

-2.5%

Dr Lalchandani Labs

₹78.0m

Provides diagnostic and related healthcare tests and services in India.

541299

₹18.00

7D

0%

1Y

n/a